Efficacy and safety of eribulin in the treatment of advanced adult soft tissue sarcoma (STS): First real-world data in Chinese population.

被引：0
|
作者：
Guo, Xi [1 ]
Zhou, Yuhong [1 ]
Zhuang, Rongyuan [1 ]
You, Yang [1 ]
Zhang, Chenlu [1 ]
Wang, Zhiming [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11577
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
    Kocher, Florian
    Seeber, Andreas
    Weiss, Lukas
    Romeder, Franz
    Szkandera, Joanna
    Kuhr, Thomas
    Kostner, Susanne
    Pichler, Petra
    Jaeger, Thomas
    Greil, Richard
    Brodowicz, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
    Ying Ni
    Yabing Dong
    Aijun Jiang
    Qun Zhang
    Zhantong Wang
    Hui Liang
    Wei Zhang
    Discover Oncology, 15 (1)
  • [23] Efficacy and safety of eribulin as a front-line treatment in patients with advanced breast cancer: The first large scale prospective real-world study in China
    Zhao, Jianli
    Dinglin, Xiao-Xiao
    Yang, Ya-Ping
    Luo, Si-Min
    Cai, Yang-Yang
    Chai, Jie
    Liu, Donggeng
    Wang, Ying
    Yao, He-Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN BRAZIL
    Melo, A. C.
    Santi, P. X.
    Nunes, D. L.
    Aleixo, S. B.
    Martins, C. L.
    de Silva, A. V. T.
    Fernandez, F. L. C.
    Beato, P. M. M.
    Guimaraes, C. M.
    Oliveira, R. W.
    Silva Julian, G.
    Souza, H.
    Gatti de Menezes, F.
    Novick, D.
    VALUE IN HEALTH, 2019, 22 : S534 - S535
  • [25] Low dose oral cyclophosphamide (LDOC) with prednisolone in the treatment of advanced adult soft tissue sarcoma (STS)
    Arouri, F.
    Lee, A.
    Harris, S.
    Jones, R.
    Miah, A.
    Benson, C.
    Judson, I.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S703 - S703
  • [26] Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
    Chung Ryul Oh
    Jung Yong Hong
    Jee Hung Kim
    Ji Sung Lee
    Hyo Song Kim
    Tae Won Kim
    Jin-Hee Ahn
    Jeong Eun Kim
    Targeted Oncology, 2020, 15 : 485 - 493
  • [27] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN THE UNITED KINGDOM
    Mytelka, D. S.
    Lorenzo, M.
    Stafkey-Mailey, D.
    D'yachkova, Y.
    Nagar, S. P.
    Candrilli, S. D.
    Kaye, J. A.
    VALUE IN HEALTH, 2016, 19 (07) : A751 - A751
  • [28] Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
    Oh, Chung Ryul
    Hong, Jung Yong
    Kim, Jee Hung
    Lee, Ji Sung
    Kim, Hyo Song
    Kim, Tae Won
    Ahn, Jin-Hee
    Kim, Jeong Eun
    TARGETED ONCOLOGY, 2020, 15 (04) : 485 - 493
  • [29] The efficacy and safety of pembrolizumab in advanced cervical cancer: A real-world treatment study
    Browne, I.
    Chew, S.
    Fennelly, D.
    Crown, J.
    Murray, H.
    Rahman, R.
    McCaffrey, J.
    Kelly, C.
    Osman, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S1438 - S1439
  • [30] Combination of trabectedin (T) and doxorubicin (D) for the treatment of patients with soft tissue sarcoma (STS): Safety and efficacy analysis
    Blay, J.
    von Mehren, M.
    Samuels, B. L.
    Fanucchi, M. P.
    Ray-Coquard, I. L.
    Buckley, B.
    Gilles, L.
    Lebedinsky, C.
    Elsayed, Y. A.
    Le Cesne, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345